271. Ankylosing spondylitis Clinical trials / Disease details
Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05666115 (ClinicalTrials.gov) | January 2, 2023 | 22/11/2022 | Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot Study | Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis | Arthritis;Rheumatic Diseases;Autoimmune Diseases | Dietary Supplement: Probiotic group;Other: Exercise group | Camilo Jose Cela University | NULL | Active, not recruiting | 18 Years | 60 Years | All | 12 | N/A | Spain |